Search Results

No Results

    Recently Viewed

    Listening...

    Sorry, I don't understand. Please try again
    1. Ireland/
    2. Our innovation /
    3. Focus areas/
    4. Immunology

    Immunology

    We understand how distressing and debilitating immune-mediated inflammatory diseases (IMIDs) can be, which is why we strive to provide treatments that give you or your loved ones relief from the daily discomfort and stress that these conditions can pose. Rest assured, we are committed to building on our breakthroughs that have already changed the lives of millions of people around the world.
    JJMTIM_Photo_PatientComfort_01_9533.jpg
    Our commitment to patients
    Johnson & Johnson is committed to help ease the challenges that people living with immune-mediated inflammatory diseases have to endure for the rest of their lives.

    Our goal is to improve the diagnosis of immune-mediated inflammatory diseases, improve patients’ access to the best possible treatments and continue to provide new and better medicines
    We never underestimate the human impact of immune-mediated inflammatory diseases
    People living with immune-mediated inflammatory diseases can be affected for the rest of their lives, yet the impact of these conditions is dramatically underestimated. As some of these diseases are not readily recognised, people can suffer silently before eventually receiving treatment.

    Immune-mediated inflammatory diseases are the result of a relentless, internal, immunological ‘storm’, which can cause pain and discomfort that many people live with every day[1], [2], [3]. People may further experience stigma, isolation, decreased productivity and psychological issues[2], [4], [5], [6], [7]. And it’s not just them, their families and loved ones can be affected too[4] .

    Our mission is clear: we won’t rest until we achieve a world free from immune-mediated inflammatory diseases.
    Our treatment areas
    We are proud to have one of the strongest treatment portfolios for some of the most common immune-mediated inflammatory diseases.
    Dermatology .webp
    Dermatology
    Our focus in Dermatology is inflammatory conditions of the skin.
    Rheumatology .webp
    Rheumatology
    Our focus in Rheumatology is currently inflammatory disorders of the joints and skin.
    Gastroenterology .webp
    Gastroenterology
    Our focus in Gastroenterology is inflammatory bowel disease.
    JJ_Photo_CorkFacility_12.jpg
    Working together to achieve a world where immune-mediated inflammatory diseases are a thing of the past
    Our commitment to immune-mediated inflammatory diseases goes beyond our medicines. We support patients through collaborations with patient advocacy organisations.

    We invest heavily in continuous medical education of doctors and care providers, uniting different therapeutic areas to share expertise and best practices.


    We also bring together the brightest minds, including doctors, nurses, patients and patient groups, scientists and policy makers to turn scientific discoveries into treatment breakthroughs, and to ensure that people can benefit from the best treatments when they need them.
    Learn more
    • GutCast
      GutCast is an award-winning podcast collaboration between J&J and Crohn’s and Colitis Ireland. It is designed for those living with Inflammatory Bowel Disease (IBD) in Ireland. Each episode brings together healthcare experts and people with IBD to answer the most common questions about managing the condition. From coping with fatigue to balancing work, social life, and mental health, listen to all episodes now.
    • My IBD Journey
      Looking for practical tips on living with inflammatory bowel disease (IBD)? Head to the My IBD Journey page, where you will find a series of short animations providing helpful advice about living well with IBD.
    • PsO Let’s Talk Psoriasis
      Living with Psoriasis or Psoriatic Arthritis? Hosted by broadcaster Dr Ciara Kelly, PsO Let’s Talk Psoriasis is an award-winning video and podcast series designed to help people manage their condition. This four-part series features healthcare experts and people living with psoriasis, offering advice on treatment options and busting common myths along the way.
    • Beyond Expectations
      If you want to learn more about psoriasis or psoriatic arthritis, check out Beyond Expectations, our online patient portal for people living with psoriatic disease or who are interested in learning more about the disease and treatment options.

    References

    [1] Lofvendahl, S., et al. Incremental costs for psoriasis and psoriatic arthritis in a population-based cohort in southern Sweden: is it all psoriasis-attributable morbidity? Journal of Rheumatology, 2016;43(3):640-647
    [2] Lonffors, S., et al. IBD and health-related quality of life - discovering the true impact. Journal of Crohn’s and Colitis, 2014;8:1281-1286
    [3] Najafi, S., et al. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach. Clin Rheumatol, 2020;39:3223–3235
    [4] Eghlileb, A.M., et al. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol, 2007;156(6):1245-50
    [5] Dibley, L., et al. The experience of stigma in inflammatory bowel disease: An interpretive (hermeneutic) phenomenological study. J Adv Nurs, 2018;74:838-851
    [6] Ograczyk, A., et al. Itch, disease coping strategies and quality of life in psoriasis patients. Postepy Dermatologi Alergologii, 2014;5:299-304
    [7] Narayanan, S., et al. 2014. Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study. Psoriasis (Auckl), 2014;5:1-7

    CP-485343 l October 2024